Article

ARVO names new officers

Peng T. Khaw, MD, PhD, FARVO, is the new president of the Association for Research in Vision and Ophthalmology (ARVO). He succeeds Jeffrey Boatright, PhD, FARVO, whose 1-year term ended in May.

Rockville, MD-Peng T. Khaw, MD, PhD, FARVO, is the new president of the Association for Research in Vision and Ophthalmology (ARVO). He succeeds Jeffrey Boatright, PhD, FARVO, whose 1-year term ended in May.

“I’m excited for the future of ARVO and honored to have the opportunity to play such a significant role in promoting its members and the field of ophthalmology and vision research in the coming year,” Dr. Khaw said.

He is director of the UK National Institute for Health Research Biomedical Research Centre of the Moorfields Eye Hospital NHS Foundation Trust and the University College London (UCL) Institute of Ophthalmology, professor at the UCL Institute of Ophthalmology, and a consultant ophthalmic surgeon at Moorfields Eye Hospital, London.

Dr. Khaw joins a new slate of officers and trustees. Jacob Pe’er, MD, FARVO, is vice president, and Craig E. Crosson, PhD, FARVO, is executive vice president.

Dr. Pe’er is professor and chairman of the department of ophthalmology at Hadassah-Hebrew University Medical Center and associate dean of Hebrew University-Hadassah Faculty of Medicine, Jerusalem. Dr. Crosson holds the Pawek-Vallotton Professor Endowed Chair and is a professor of ophthalmology and senior associate dean for research at the Medical University of South Carolina, Charleston.

The three new trustees serving 5-year terms on the ARVO board: Paul S. Bernstein, MD, PhD, FARVO, representing the biochemistry and molecular biology section; Emily Y. Chew, MD, FARVO, representing the clinical and epidemiologic research section; and Peter D. Lukasiewicz, PhD, representing the visual neuroscience section.

Dr. Bernstein is an associate professor of ophthalmology and visual sciences at the University of Utah School of Medicine, Salt Lake City. Dr. Chew is the deputy director of the division of epidemiology and clinical applications and the deputy clinical director at the National Eye Institute of the National Institutes of Health. Dr. Lukasiewicz is a professor and director of research in the department of ophthalmology and visual sciences and a professor in the department of anatomy and neurobiology at Washington University School of Medicine in St. Louis.

Justine Smith, MBBS, PhD, FARVO, has been named president-elect and will serve the 2013-to-2014 term. John S. Penn, PhD, FARVO, and David R. Williams, PhD, FARVO, are the vice presidents-elect who will serve during that term.

Dr. Smith is the Schnitzer Professor of Ophthalmic Research and an associate professor of ophthalmology and cell and developmental biology at the Casey Eye Institute, Oregon Health and Science University, Portland. Dr. Penn is the Phyllis G. and William B. Snyder Professor of Ophthalmology, director of research and vice chairman in the department of ophthalmology and visual sciences, and a professor of pharmacology and cell and developmental biology at Vanderbilt University School of Medicine, Nashville. Dr. Williams is the William G. Allyn Professor of Medical Optics, director of the Center for Visual Science, and a professor of brain and cognitive sciences, optics, ophthalmology, and biomedical engineering at University of Rochester in New York.

For more articles in this issue of Ophthalmology Times eReport, click here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.